We are live on
!
Find out more
TI
Turner Investments Portfolio holdings
AUM
$134K
1-Year Est. Return
49.03%
This Fund
S&P 500
This Quarter
Est. Return
+6.57%
1 Year Est. Return
-49.03%
3 Year Est. Return
+6.36%
5 Year Est. Return
+75.79%
10 Year Est. Return
–
AUM
$248M
AUM Growth
-$54.7M
(-18%)
Cap. Flow
-$53.1M
Cap. Flow
% of AUM
-21.45%
Top 10 Holdings %
Top 10 Hldgs %
14.37%
Holding
315
New
136
Increased
18
Reduced
93
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Idexx Laboratories
IDXX
|
+$3.08M |
| 2 |
United Rentals
URI
|
+$3.05M |
| 3 |
HDS
HD Supply Holdings, Inc.
HDS
|
+$2.72M |
| 4 |
XYZ
Block Inc
XYZ
|
+$2.61M |
| 5 |
SBA Communications
SBAC
|
+$2.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PARA
Paramount Global Class B
PARA
|
+$5.27M |
| 2 |
NXP Semiconductors
NXPI
|
+$4.94M |
| 3 |
ACHN
Achillion Pharmaceuticals
ACHN
|
+$4.67M |
| 4 |
ZAYO
Zayo Group Holdings, Inc.
ZAYO
|
+$4.24M |
| 5 |
Aramark
ARMK
|
+$4.09M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.81% |
| 2 | Technology | 18.88% |
| 3 | Industrials | 12.19% |
| 4 | Consumer Discretionary | 11.96% |
| 5 | Financials | 7.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABMD
26
DELISTED
Abiomed Inc
ABMD
| $2.25M | 0.91% |
20,000
+3,000
| +18% | +$348K |
|
27
Monolithic Power Systems
MPWR
$66.5B
| $2.23M | 0.9% |
27,150
-45,770
| -63% | -$3.67M |
|
28
Intuitive Surgical
ISRG
$133B
| $2.21M | 0.89% |
31,320
-26,820
| -46% | -$1.97M |
|
|
VISN
29
Vistance Networks Inc
VISN
$2.67B
| $2.2M | 0.89% |
+59,100
| New | +$2.01M |
|
30
Ulta Beauty
ULTA
$22.8B
| $2.19M | 0.89% |
8,600
-660
| -7% | -$165K |
|
31
Ionis Pharmaceuticals
IONS
$8.84B
| $2.17M | 0.88% |
45,360
+2,820
| +7% | +$112K |
|
32
Omnicom Group
OMC
$21.9B
| $2.05M | 0.83% |
+24,080
| New | +$2.02M |
|
33
Zions Bancorporation
ZION
$10.3B
| $2.04M | 0.83% |
+47,460
| New | +$1.75M |
|
34
Huntington Bancshares
HBAN
$34.7B
| $2.02M | 0.82% |
+153,220
| New | +$1.79M |
|
35
Paychex
PAYX
$42B
| $2.01M | 0.81% |
+33,000
| New | +$1.9M |
|
36
Incyte
INCY
$24.1B
| $2.01M | 0.81% |
+20,000
| New | +$1.95M |
|
|
NUVA
37
DELISTED
NuVasive, Inc.
NUVA
| $1.97M | 0.8% |
29,300
-12,200
| -29% | -$786K |
|
38
Middleby
MIDD
$6.08B
| $1.97M | 0.8% |
+15,310
| New | +$1.93M |
|
39
NVIDIA
NVDA
$5.01T
| $1.92M | 0.78% |
+720,000
| New | +$1.5M |
|
40
Lam Research
LRCX
$366B
| $1.9M | 0.77% |
180,000
-401,100
| -69% | -$4.07M |
|
|
MARK
41
DELISTED
Remark Holdings, Inc.
MARK
| $1.88M | 0.76% |
47,900
-4,600
| -9% | -$188K |
|
42
Hershey
HSY
$35.4B
| $1.85M | 0.75% |
+17,890
| New | +$1.77M |
|
43
Conagra Brands
CAG
$7.03B
| $1.84M | 0.74% |
+46,450
| New | +$1.74M |
|
44
Mettler-Toledo International
MTD
$28.7B
| $1.83M | 0.74% |
+4,380
| New | +$1.82M |
|
|
ZAYO
45
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $1.81M | 0.73% |
55,040
-129,530
| -70% | -$4.24M |
|
46
Nucor
NUE
$58.6B
| $1.78M | 0.72% |
+30,000
| New | +$1.68M |
|
47
Cboe Global Markets
CBOE
$30.9B
| $1.77M | 0.72% |
+24,000
| New | +$1.65M |
|
|
PRAH
48
DELISTED
PRA Health Sciences, Inc.
PRAH
| $1.71M | 0.69% |
31,000
-19,000
| -38% | -$1.04M |
|
49
MasTec
MTZ
$20.6B
| $1.68M | 0.68% |
+44,010
| New | +$1.49M |
|
|
BUFF
50
DELISTED
Blue Buffalo Pet Products, Inc
BUFF
| $1.6M | 0.65% |
66,650
+11,650
| +21% | +$282K |
|
Similar funds
IP
DVC
PAM
CCM
GA
IPLA
LRM
HC
Turner Investments's Q4 2016 Portfolio in Review
As of Q4 2016, Turner Investments held 315 positions worth $248M, down 18% from $302M the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Turner Investments withdrew a net $53.1M in Q4 2016, closing 58 positions and reducing 93 holdings. Its most notable exit was Aramark, an estimated $4.09M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 31% a quarter earlier, followed by Technology and Industrials.
Against the trend, Turner Investments opened a new position in Idexx Laboratories worth $3.17M.
- Turner Investments's largest Q4 2016 buy was Idexx Laboratories: 27,000 shares worth $3.17M.
- Turner Investments added most to bluebird bio in Q4 2016, an estimated $1.26M increase.
- Turner Investments's biggest Q4 2016 reduction was Paramount Global Class B, cutting an estimated $5.27M.
- Turner Investments fully exited Aramark in Q4 2016, selling an estimated $4.09M.
- Turner Investments's ten largest holdings make up 14% of its $248M portfolio in Q4 2016.
- Turner Investments opened 136 new positions and closed 58 in Q4 2016.
- Turner Investments's portfolio value fell 18% quarter-over-quarter to $248M.
Based on Turner Investments's 13F filing for Q4 2016, filed 8 Feb 2017.